The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA approval for it. And the larger the drug target group is, the more exciting it can be. Puma Biotechnology Inc. (NASDAQ: PBYI) announced last summer that it had received approval by the U.S. …
0 Comments